• News
Jun 25, 2020
Mariposa Therapeutics founded as a spin-out from Neem Biotech to advance new Epidermolysis Bullosa Simplex treatment

Mariposa Therapeutics, a new private biotech company developing a novel topical treatment for patients with epidermolysis bullosa simplex (EBS) was established as a spin out from Neem Biotech, a......